Patients and their families work with NIH researchers to advance MMA research

Dr. Chuck Venditti, a senior investigator in the National Human Genome Research Institute, is working with the largest group of people affected by methylmalonic acidemia (MMA). The disease impairs an individual's ability to break down and process protein in their food. As a result, toxic acids can build up in the bloodstream and cause serious health problems. Dr. Venditti and his dedicated research team will soon begin clinical trials to test several new genomic treatments.
Source: NHGRI Homepage Highlights - Category: Genetics & Stem Cells Source Type: news